Divi's Laboratories's Other Operating Expense for the
three
months ended in Mar. 2026 was ₹8,980 Mil.
Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was ₹34,890 Mil.
Divi's Laboratories's quarterly Other Operating Expense
increased
from Sep. 2025 (₹8,670 Mil) to Dec. 2025 (₹8,870 Mil) and
increased
from Dec. 2025 (₹8,870 Mil) to Mar. 2026 (₹8,980 Mil).
Divi's Laboratories's annual Other Operating Expense
increased
from Mar. 2024 (₹24,450 Mil) to Mar. 2025 (₹27,630 Mil) and
increased
from Mar. 2025 (₹27,630 Mil) to Mar. 2026 (₹34,890 Mil).
Divi's Laboratories Other Operating Expense Related Terms
Divi's Laboratories Other Operating Expense Historical Data
* Premium members only.
The historical data trend for Divi's Laboratories's Other Operating Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)
Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.
Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹34,890 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Other Operating Expense of ₹34,890 Mil mean?
Divi's Laboratories (NSE:DIVISLAB) has a Other Operating Expense of ₹34,890 Mil as of Mar. 2026. Other operating expenses that a company records on its income statement. View historical data on Divi's Laboratories and its competitors.
Is Divi's Laboratories' Other Operating Expense too high?
Divi's Laboratories' current Other Operating Expense is ₹34,890 Mil. Overall, Divi's Laboratories has a GF Score™ of 94/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Divi's Laboratories' Other Operating Expense compare to ZTS and UTHR?
Divi's Laboratories' Other Operating Expense of ₹34,890 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Drug Manufacturers company?
A good Other Operating Expense depends on the Drug Manufacturers industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Divi's Laboratories and its competitors. Divi's Laboratories's current Other Operating Expense is ₹34,890 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Divi's Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Divi's Laboratories (NSE:DIVISLAB) is currently considered Fairly Valued. The stock's GF Value™ is ₹6,764.19, compared to a current price of ₹6,771.50 — trading 0.1% above its estimated fair value. The current Other Operating Expense is ₹34,890 Mil. Divi's Laboratories' overall GF Score™ is 94/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Divi's Laboratories (NSE:DIVISLAB), the current Other Operating Expense is ₹34,890 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Divi's Laboratories (NSE:DIVISLAB) Overvalued in 2026?
Based on GuruFocus' analysis, Divi's Laboratories stock appears to be overvalued.
The current stock price of ₹6,771.50 is trading 0.1% above its estimated GF Value™ of ₹6,764.19.
GuruFocus considers Divi's Laboratories to be Fairly Valued.
Key valuation signals for NSE:DIVISLAB:
Other Operating Expense: ₹34,890 Mil
GF Value™: ₹6,764.19 vs. price of ₹6,771.50 (0.1% above fair value)
No single metric tells the full story. See the NSE:DIVISLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Divi's Laboratories Ltd is a specialty and generic drug manufacturing company. It is engaged in the manufacture of Active Pharmaceutical ingredients (API), Intermediates, and Nutraceutical ingredients, with a predominance in exports. It also, through its custom synthesis, supports pharma companies for their patented products business from gram-scale requirements for clinical trials to launch, as well as late-life cycle management. Geographically, the company derives maximum revenue from Europe, and the rest from America, India, Asia (excluding India), and the Rest of the world.
94GF Score
Get the complete analysis for NSE:DIVISLAB
Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:DIVISLAB has been successfully added to your 
